(VRSK) Verisk Analytics - Overview
Exchange: NASDAQ •
Country: United States •
Currency: USD •
Type: Common Stock •
ISIN: US92345Y1064
Stock: Analytics, Underwriting, Claims, Catastrophe, Fraud
Total Rating 54
Risk 96
Buy Signal -1.36
EPS (Earnings per Share)
Revenue
Dividends
| Dividend Yield | 0.69% |
| Yield on Cost 5y | 1.00% |
| Yield CAGR 5y | 11.61% |
| Payout Consistency | 100.0% |
| Payout Ratio | 25.9% |
| Risk 5d forecast | |
|---|---|
| Volatility | 20.3% |
| Relative Tail Risk | -5.51% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | -1.10 |
| Alpha | -30.00 |
| Character TTM | |
|---|---|
| Beta | 0.271 |
| Beta Downside | 0.256 |
| Drawdowns 3y | |
|---|---|
| Max DD | 35.06% |
| CAGR/Max DD | 0.16 |
Description: VRSK Verisk Analytics December 17, 2025
Verisk Analytics, Inc. (NASDAQ: VRSK) supplies data-analytics and technology services to insurers worldwide, covering underwriting, claims, fraud detection, catastrophe modelling, and specialty-business management. Its offerings span rule-based underwriting forms, loss-cost analytics, workflow automation, and international solutions for both property-casualty and life insurance markets.
Key metrics (FY 2023) show revenue of roughly $3.1 billion with an operating margin near 22 %, driven largely by subscription-based recurring revenue that now represents about 70 % of total sales. The company’s growth is anchored to macro-level drivers such as rising natural-catastrophe frequency, which fuels demand for its extreme-event modelling, and tightening regulatory environments that increase the need for compliance and anti-fraud tools. Additionally, the broader insurance-tech sector is seeing a shift toward AI-enhanced underwriting, positioning Verisk’s data assets as a competitive moat.
If you’re evaluating how Verisk’s platform stacks up against newer analytics players, a quick look at ValueRay’s product suite could provide useful context.
Piotroski VR‑10 (Strict, 0-10) 5.5
| Net Income: 921.4m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.18 > 0.02 and ΔFCF/TA -2.02 > 1.0 |
| NWC/Revenue: 14.40% < 20% (prev -8.59%; Δ 22.98% < -1%) |
| CFO/TA 0.22 > 3% & CFO 1.35b > Net Income 921.4m |
| Net Debt (2.78b) to EBITDA (1.66b): 1.68 < 3 |
| Current Ratio: 1.19 > 1.5 & < 3 |
| Outstanding Shares: last quarter (139.9m) vs 12m ago -1.80% < -2% |
| Gross Margin: 69.62% > 18% (prev 0.68%; Δ 6894 % > 0.5%) |
| Asset Turnover: 56.08% > 50% (prev 61.87%; Δ -5.80% > 0%) |
| Interest Coverage Ratio: 9.09 > 6 (EBITDA TTM 1.66b / Interest Expense TTM 148.5m) |
Altman Z'' 7.54
| A: 0.07 (Total Current Assets 2.70b - Total Current Liabilities 2.26b) / Total Assets 6.24b |
| B: 1.23 (Retained Earnings 7.68b / Total Assets 6.24b) |
| C: 0.25 (EBIT TTM 1.35b / Avg Total Assets 5.40b) |
| D: 1.33 (Book Value of Equity 7.78b / Total Liabilities 5.86b) |
| Altman-Z'' Score: 7.54 = AAA |
Beneish M -3.39
| DSRI: 0.77 (Receivables 436.8m/526.6m, Revenue 3.03b/2.82b) |
| GMI: 0.98 (GM 69.62% / 68.24%) |
| AQI: 0.77 (AQ_t 0.45 / AQ_t-1 0.59) |
| SGI: 1.07 (Revenue 3.03b / 2.82b) |
| TATA: -0.07 (NI 921.4m - CFO 1.35b) / TA 6.24b) |
| Beneish M-Score: -3.39 (Cap -4..+1) = AA |
What is the price of VRSK shares?
As of January 30, 2026, the stock is trading at USD 216.59 with a total of 1,218,937 shares traded.
Over the past week, the price has changed by -0.87%, over one month by -3.63%, over three months by +4.35% and over the past year by -22.83%.
Over the past week, the price has changed by -0.87%, over one month by -3.63%, over three months by +4.35% and over the past year by -22.83%.
Is VRSK a buy, sell or hold?
Verisk Analytics has received a consensus analysts rating of 3.39.
Therefor, it is recommend to hold VRSK.
- StrongBuy: 3
- Buy: 3
- Hold: 10
- Sell: 2
- StrongSell: 0
What are the forecasts/targets for the VRSK price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 249.3 | 15.1% |
| Analysts Target Price | 249.3 | 15.1% |
| ValueRay Target Price | 218.7 | 1% |
VRSK Fundamental Data Overview January 27, 2026
P/E Trailing = 33.5446
P/E Forward = 28.6533
P/S = 10.0556
P/B = 80.6711
P/EG = 2.7384
Revenue TTM = 3.03b USD
EBIT TTM = 1.35b USD
EBITDA TTM = 1.66b USD
Long Term Debt = 3.21b USD (from longTermDebt, last quarter)
Short Term Debt = 1.52b USD (from shortTermDebt, last quarter)
Debt = 4.89b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 2.78b USD (from netDebt column, last quarter)
Enterprise Value = 33.24b USD (30.46b + Debt 4.89b - CCE 2.11b)
Interest Coverage Ratio = 9.09 (Ebit TTM 1.35b / Interest Expense TTM 148.5m)
EV/FCF = 29.79x (Enterprise Value 33.24b / FCF TTM 1.12b)
FCF Yield = 3.36% (FCF TTM 1.12b / Enterprise Value 33.24b)
FCF Margin = 36.83% (FCF TTM 1.12b / Revenue TTM 3.03b)
Net Margin = 30.41% (Net Income TTM 921.4m / Revenue TTM 3.03b)
Gross Margin = 69.62% ((Revenue TTM 3.03b - Cost of Revenue TTM 920.3m) / Revenue TTM)
Gross Margin QoQ = 70.13% (prev 70.30%)
Tobins Q-Ratio = 5.33 (Enterprise Value 33.24b / Total Assets 6.24b)
Interest Expense / Debt = 0.86% (Interest Expense 42.2m / Debt 4.89b)
Taxrate = 25.36% (76.6m / 302.1m)
NOPAT = 1.01b (EBIT 1.35b * (1 - 25.36%))
Current Ratio = 1.19 (Total Current Assets 2.70b / Total Current Liabilities 2.26b)
Debt / Equity = 12.98 (Debt 4.89b / totalStockholderEquity, last quarter 376.7m)
Debt / EBITDA = 1.68 (Net Debt 2.78b / EBITDA 1.66b)
Debt / FCF = 2.49 (Net Debt 2.78b / FCF TTM 1.12b)
Total Stockholder Equity = 227.9m (last 4 quarters mean from totalStockholderEquity)
RoA = 17.05% (Net Income 921.4m / Total Assets 6.24b)
RoE = 404.3% (Net Income TTM 921.4m / Total Stockholder Equity 227.9m)
RoCE = 39.23% (EBIT 1.35b / Capital Employed (Equity 227.9m + L.T.Debt 3.21b))
RoIC = 25.92% (NOPAT 1.01b / Invested Capital 3.89b)
WACC = 6.05% (E(30.46b)/V(35.35b) * Re(6.92%) + D(4.89b)/V(35.35b) * Rd(0.86%) * (1-Tc(0.25)))
Discount Rate = 6.92% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 7.95%
Shares Correlation 3-Years: -100.0 | Cagr: -1.89%
[DCF Debug] Terminal Value 86.69% ; FCFF base≈1.03b ; Y1≈1.14b ; Y5≈1.48b
Fair Price DCF = 278.5 (EV 41.59b - Net Debt 2.78b = Equity 38.81b / Shares 139.4m; r=6.05% [WACC]; 5y FCF grow 12.29% → 2.90% )
EPS Correlation: -20.32 | EPS CAGR: -45.57% | SUE: -4.0 | # QB: 0
Revenue Correlation: 35.24 | Revenue CAGR: 0.08% | SUE: -1.49 | # QB: 0
EPS next Quarter (2026-03-31): EPS=1.84 | Chg30d=+0.017 | Revisions Net=+3 | Analysts=13
EPS next Year (2026-12-31): EPS=7.71 | Chg30d=+0.053 | Revisions Net=+3 | Growth EPS=+11.1% | Growth Revenue=+6.7%
P/E Forward = 28.6533
P/S = 10.0556
P/B = 80.6711
P/EG = 2.7384
Revenue TTM = 3.03b USD
EBIT TTM = 1.35b USD
EBITDA TTM = 1.66b USD
Long Term Debt = 3.21b USD (from longTermDebt, last quarter)
Short Term Debt = 1.52b USD (from shortTermDebt, last quarter)
Debt = 4.89b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 2.78b USD (from netDebt column, last quarter)
Enterprise Value = 33.24b USD (30.46b + Debt 4.89b - CCE 2.11b)
Interest Coverage Ratio = 9.09 (Ebit TTM 1.35b / Interest Expense TTM 148.5m)
EV/FCF = 29.79x (Enterprise Value 33.24b / FCF TTM 1.12b)
FCF Yield = 3.36% (FCF TTM 1.12b / Enterprise Value 33.24b)
FCF Margin = 36.83% (FCF TTM 1.12b / Revenue TTM 3.03b)
Net Margin = 30.41% (Net Income TTM 921.4m / Revenue TTM 3.03b)
Gross Margin = 69.62% ((Revenue TTM 3.03b - Cost of Revenue TTM 920.3m) / Revenue TTM)
Gross Margin QoQ = 70.13% (prev 70.30%)
Tobins Q-Ratio = 5.33 (Enterprise Value 33.24b / Total Assets 6.24b)
Interest Expense / Debt = 0.86% (Interest Expense 42.2m / Debt 4.89b)
Taxrate = 25.36% (76.6m / 302.1m)
NOPAT = 1.01b (EBIT 1.35b * (1 - 25.36%))
Current Ratio = 1.19 (Total Current Assets 2.70b / Total Current Liabilities 2.26b)
Debt / Equity = 12.98 (Debt 4.89b / totalStockholderEquity, last quarter 376.7m)
Debt / EBITDA = 1.68 (Net Debt 2.78b / EBITDA 1.66b)
Debt / FCF = 2.49 (Net Debt 2.78b / FCF TTM 1.12b)
Total Stockholder Equity = 227.9m (last 4 quarters mean from totalStockholderEquity)
RoA = 17.05% (Net Income 921.4m / Total Assets 6.24b)
RoE = 404.3% (Net Income TTM 921.4m / Total Stockholder Equity 227.9m)
RoCE = 39.23% (EBIT 1.35b / Capital Employed (Equity 227.9m + L.T.Debt 3.21b))
RoIC = 25.92% (NOPAT 1.01b / Invested Capital 3.89b)
WACC = 6.05% (E(30.46b)/V(35.35b) * Re(6.92%) + D(4.89b)/V(35.35b) * Rd(0.86%) * (1-Tc(0.25)))
Discount Rate = 6.92% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 7.95%
Shares Correlation 3-Years: -100.0 | Cagr: -1.89%
[DCF Debug] Terminal Value 86.69% ; FCFF base≈1.03b ; Y1≈1.14b ; Y5≈1.48b
Fair Price DCF = 278.5 (EV 41.59b - Net Debt 2.78b = Equity 38.81b / Shares 139.4m; r=6.05% [WACC]; 5y FCF grow 12.29% → 2.90% )
EPS Correlation: -20.32 | EPS CAGR: -45.57% | SUE: -4.0 | # QB: 0
Revenue Correlation: 35.24 | Revenue CAGR: 0.08% | SUE: -1.49 | # QB: 0
EPS next Quarter (2026-03-31): EPS=1.84 | Chg30d=+0.017 | Revisions Net=+3 | Analysts=13
EPS next Year (2026-12-31): EPS=7.71 | Chg30d=+0.053 | Revisions Net=+3 | Growth EPS=+11.1% | Growth Revenue=+6.7%